"Psilocybin, or "magic mushrooms," is a psychedelic medicine used for thousands of years by indigenous peoples for its healing properties. Many people hear "magic mushrooms" and imagine the 1960's hippy counterculture movement, involving excessive recreational drug use. But what many don't know is that there has been a growing body of research over the past few decades demonstrating that psilocybin has incredible potential to treat many mental health conditions, including depression, PTSD, addiction, anxiety, OCD, PTSD, and end-of-life existential distress."
"This week, outgoing Governor Murphy of New Jersey signed Bill 2830, paving the way for three chosen New Jersey hospitals to develop psilocybin therapy pilot programs. New Jersey is following in the footsteps of other pioneering states, including Colorado, Oregon, and New Mexico. Bill 2830 will allocate 6 million in funds to create a psilocybin therapy program based on protocols used in FDA studies. Data will be collected over a two-year period that will inform next steps, which many hope will mean expanding access to qualifying New Jersey residents."
Psilocybin has a long history of indigenous medicinal use and recent research shows potential to treat depression, PTSD, addiction, anxiety, OCD, and end-of-life existential distress. Federal law currently prohibits psilocybin, prompting state-level initiatives to explore regulated therapeutic models. New Jersey enacted Bill 2830 to fund a controlled pilot program at three hospitals using protocols modeled on FDA studies. The bill provides 6 million in funding and requires two years of data collection to inform future policy and potential expansion to qualifying residents. The program follows a medicalized model as an initial, cautious rollout.
Read at Psychology Today
Unable to calculate read time
Collection
[
|
...
]